Selected research
Market Structure
Global Livestock Anti-infectives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Livestock Anti-infectives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Livestock Anti-infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Livestock Anti-infectives include Bimeda Animal Health, Boehringer Ingelheim, Ceva Sante Animale, Chanelle, Elanco, Vetoquinol, Virbac, Bayer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Livestock Anti-infectives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Livestock Anti-infectives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Livestock Anti-infectives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Livestock Anti-infectives market size, projected growth trends, production technologies, key applications, and end-use industries.
Livestock Anti-infectives Segment by Company
Bimeda Animal Health
Boehringer Ingelheim
Ceva Sante Animale
Chanelle
Elanco
Vetoquinol
Virbac
Bayer
Merck
Zoetis
Livestock Anti-infectives Segment by Type
External Use
Internal Use
Livestock Anti-infectives Segment by Application
Other
Sheep
Cattle
Pigs
Livestock Anti-infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Livestock Anti-infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Livestock Anti-infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Livestock Anti-infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Livestock Anti-infectives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Livestock Anti-infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Livestock Anti-infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Livestock Anti-infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- External Use
- Internal Use
Applications
- Other
- Sheep
- Cattle
- Pigs
Companies covered
- Bimeda Animal Health
- Boehringer Ingelheim
- Ceva Sante Animale
- Chanelle
- Elanco
- Vetoquinol
- Virbac
- Bayer
- Merck
- Zoetis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Livestock Anti-infectives Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Livestock Anti-infectives Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Livestock Anti-infectives Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Livestock Anti-infectives Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Livestock Anti-infectives Market Dynamics
- 2.1 Livestock Anti-infectives Industry Trends
- 2.2 Livestock Anti-infectives Industry Drivers
- 2.3 Livestock Anti-infectives Industry Opportunities and Challenges
- 2.4 Livestock Anti-infectives Industry Restraints
3 Livestock Anti-infectives Market by Manufacturers
- 3.1 Global Livestock Anti-infectives Revenue by Manufacturers (2021-2026)
- 3.2 Global Livestock Anti-infectives Sales by Manufacturers (2021-2026)
- 3.3 Global Livestock Anti-infectives Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Livestock Anti-infectives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Livestock Anti-infectives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Livestock Anti-infectives Manufacturers, Product Type & Application
- 3.7 Global Livestock Anti-infectives Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Livestock Anti-infectives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Livestock Anti-infectives Players Market Share by Revenue in 2025
- 3.8.3 2025 Livestock Anti-infectives Tier 1, Tier 2, and Tier 3
4 Livestock Anti-infectives Market by Type
- 4.1 Livestock Anti-infectives Type Introduction
- 4.1.1 External Use
- 4.1.2 Internal Use
- 4.2 Global Livestock Anti-infectives Sales by Type
- 4.2.1 Global Livestock Anti-infectives Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Livestock Anti-infectives Sales by Type (2021-2032)
- 4.2.3 Global Livestock Anti-infectives Sales Market Share by Type (2021-2032)
- 4.3 Global Livestock Anti-infectives Revenue by Type
- 4.3.1 Global Livestock Anti-infectives Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Livestock Anti-infectives Revenue by Type (2021-2032)
- 4.3.3 Global Livestock Anti-infectives Revenue Market Share by Type (2021-2032)
5 Livestock Anti-infectives Market by Application
- 5.1 Livestock Anti-infectives Application Introduction
- 5.1.1 Other
- 5.1.2 Sheep
- 5.1.3 Cattle
- 5.1.4 Pigs
- 5.2 Global Livestock Anti-infectives Sales by Application
- 5.2.1 Global Livestock Anti-infectives Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Livestock Anti-infectives Sales by Application (2021-2032)
- 5.2.3 Global Livestock Anti-infectives Sales Market Share by Application (2021-2032)
- 5.3 Global Livestock Anti-infectives Revenue by Application
- 5.3.1 Global Livestock Anti-infectives Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Livestock Anti-infectives Revenue by Application (2021-2032)
- 5.3.3 Global Livestock Anti-infectives Revenue Market Share by Application (2021-2032)
6 Global Livestock Anti-infectives Sales by Region
- 6.1 Global Livestock Anti-infectives Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Livestock Anti-infectives Sales by Region (2021-2032)
- 6.2.1 Global Livestock Anti-infectives Sales by Region (2021-2026)
- 6.2.2 Global Livestock Anti-infectives Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Livestock Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Livestock Anti-infectives Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Livestock Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Livestock Anti-infectives Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Livestock Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Livestock Anti-infectives Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Livestock Anti-infectives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Livestock Anti-infectives Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Livestock Anti-infectives Revenue by Region
- 7.1 Global Livestock Anti-infectives Revenue by Region
- 7.1.1 Global Livestock Anti-infectives Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Livestock Anti-infectives Revenue by Region (2021-2026)
- 7.1.3 Global Livestock Anti-infectives Revenue by Region (2027-2032)
- 7.1.4 Global Livestock Anti-infectives Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Livestock Anti-infectives Revenue (2021-2032)
- 7.2.2 North America Livestock Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Livestock Anti-infectives Revenue (2021-2032)
- 7.3.2 Europe Livestock Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Livestock Anti-infectives Revenue (2021-2032)
- 7.4.2 Asia-Pacific Livestock Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Livestock Anti-infectives Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Livestock Anti-infectives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Bimeda Animal Health
- 8.1.1 Bimeda Animal Health Company Information
- 8.1.2 Bimeda Animal Health Business Overview
- 8.1.3 Bimeda Animal Health Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Bimeda Animal Health Livestock Anti-infectives Product Portfolio
- 8.1.5 Bimeda Animal Health Recent Developments
- 8.2 Boehringer Ingelheim
- 8.2.1 Boehringer Ingelheim Company Information
- 8.2.2 Boehringer Ingelheim Business Overview
- 8.2.3 Boehringer Ingelheim Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Boehringer Ingelheim Livestock Anti-infectives Product Portfolio
- 8.2.5 Boehringer Ingelheim Recent Developments
- 8.3 Ceva Sante Animale
- 8.3.1 Ceva Sante Animale Company Information
- 8.3.2 Ceva Sante Animale Business Overview
- 8.3.3 Ceva Sante Animale Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ceva Sante Animale Livestock Anti-infectives Product Portfolio
- 8.3.5 Ceva Sante Animale Recent Developments
- 8.4 Chanelle
- 8.4.1 Chanelle Company Information
- 8.4.2 Chanelle Business Overview
- 8.4.3 Chanelle Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chanelle Livestock Anti-infectives Product Portfolio
- 8.4.5 Chanelle Recent Developments
- 8.5 Elanco
- 8.5.1 Elanco Company Information
- 8.5.2 Elanco Business Overview
- 8.5.3 Elanco Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Elanco Livestock Anti-infectives Product Portfolio
- 8.5.5 Elanco Recent Developments
- 8.6 Vetoquinol
- 8.6.1 Vetoquinol Company Information
- 8.6.2 Vetoquinol Business Overview
- 8.6.3 Vetoquinol Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Vetoquinol Livestock Anti-infectives Product Portfolio
- 8.6.5 Vetoquinol Recent Developments
- 8.7 Virbac
- 8.7.1 Virbac Company Information
- 8.7.2 Virbac Business Overview
- 8.7.3 Virbac Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Virbac Livestock Anti-infectives Product Portfolio
- 8.7.5 Virbac Recent Developments
- 8.8 Bayer
- 8.8.1 Bayer Company Information
- 8.8.2 Bayer Business Overview
- 8.8.3 Bayer Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bayer Livestock Anti-infectives Product Portfolio
- 8.8.5 Bayer Recent Developments
- 8.9 Merck
- 8.9.1 Merck Company Information
- 8.9.2 Merck Business Overview
- 8.9.3 Merck Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Merck Livestock Anti-infectives Product Portfolio
- 8.9.5 Merck Recent Developments
- 8.10 Zoetis
- 8.10.1 Zoetis Company Information
- 8.10.2 Zoetis Business Overview
- 8.10.3 Zoetis Livestock Anti-infectives Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Zoetis Livestock Anti-infectives Product Portfolio
- 8.10.5 Zoetis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Livestock Anti-infectives Value Chain Analysis
- 9.1.1 Livestock Anti-infectives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Livestock Anti-infectives Production Mode & Process
- 9.2 Livestock Anti-infectives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Livestock Anti-infectives Distributors
- 9.2.3 Livestock Anti-infectives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst